GPT and metabolic dysfunction-associated steatotic liver disease: In 56% of the studies included in the meta-analysis by Anderson et al. NAFLD was diagnosed by ultrasound and in further 44% by elevated alanine-transaminase [4], whereas in our study quantification of steatosis was analyzed by CAP (FibroScan® M-probe) using a threshold for CAP values from a reference data set [16].